42 related articles for article (PubMed ID: 28892793)
21. [Experience with vascular endothelial growth factor inhibitors used in ophthalmologic care].
Khalaim AV; Stoliarenko GE
Vestn Oftalmol; 2007; 123(5):54-6, preceding 56. PubMed ID: 18078062
[No Abstract] [Full Text] [Related]
22. An evidence-based review of vascular endothelial growth factor inhibition in pediatric retinal diseases: part 2. Coats' disease, best disease, and uveitis with childhood neovascularization.
Chaudhary KM; Mititelu M; Lieberman RM
J Pediatr Ophthalmol Strabismus; 2013; 50(1):11-9. PubMed ID: 22938515
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological Potential of Small Molecules for Treating Corneal Neovascularization.
Barry Z; Park B; Corson TW
Molecules; 2020 Jul; 25(15):. PubMed ID: 32751576
[TBL] [Abstract][Full Text] [Related]
24. Antiangiogenic compounds: well-established drugs versus emerging natural molecules.
Ribeiro A; Abreu RMV; Dias MM; Barreiro MF; Ferreira ICFR
Cancer Lett; 2018 Feb; 415():86-105. PubMed ID: 29222042
[TBL] [Abstract][Full Text] [Related]
25. Corticosteroids as antiangiogenic agents.
Oliver A; Ciulla TA
Ophthalmol Clin North Am; 2006 Sep; 19(3):345-51, v. PubMed ID: 16935209
[TBL] [Abstract][Full Text] [Related]
26. Current and investigational pharmacotherapeutic approaches for modulating retinal angiogenesis.
Todorich B; Yiu G; Hahn P
Expert Rev Clin Pharmacol; 2014 May; 7(3):375-91. PubMed ID: 24580084
[TBL] [Abstract][Full Text] [Related]
27. Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease.
Tolentino M
Surv Ophthalmol; 2011; 56(2):95-113. PubMed ID: 21335144
[TBL] [Abstract][Full Text] [Related]
28. [New perspectives in the approach to age-related macular degeneration].
Gallego-Pinazo R; Zapata MA
Arch Soc Esp Oftalmol; 2015 Mar; 90 Suppl 1():11-4. PubMed ID: 25925046
[TBL] [Abstract][Full Text] [Related]
29. Ocular neovascularization: basic mechanisms and therapeutic advances.
Dorrell M; Uusitalo-Jarvinen H; Aguilar E; Friedlander M
Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S3-19. PubMed ID: 17240254
[TBL] [Abstract][Full Text] [Related]
30. Platelet-Derived Growth Factor Inhibitors: A Potential Therapeutic Approach for Ocular Neovascularization.
Sadiq MA; Hanout M; Sarwar S; Hassan M; Agarwal A; Sepah YJ; Do DV; Nguyen QD
Dev Ophthalmol; 2016; 55():310-6. PubMed ID: 26501397
[TBL] [Abstract][Full Text] [Related]
31. Retinal and choroidal microangiopathies: therapeutic opportunities.
Afzal A; Shaw LC; Ljubimov AV; Boulton ME; Segal MS; Grant MB
Microvasc Res; 2007; 74(2-3):131-44. PubMed ID: 17585951
[TBL] [Abstract][Full Text] [Related]
32. Antiangiogenic agents in natural products for the treatment of gynecologic disorders.
Aghamohammadi A; Hosseinimehr SJ
Nutr Cancer; 2014; 66(2):206-13. PubMed ID: 24410431
[TBL] [Abstract][Full Text] [Related]
33. Resistance to antiangiogenic therapies.
Bartolotti M; Franceschi E; Poggi R; Tosoni A; Di Battista M; Brandes AA
Future Oncol; 2014 Jun; 10(8):1417-25. PubMed ID: 25052752
[TBL] [Abstract][Full Text] [Related]
34. Antiangiogenesis beyond VEGF inhibition: a journey from antiangiogenic single-target to broad-spectrum agents.
Limaverde-Sousa G; Sternberg C; Ferreira CG
Cancer Treat Rev; 2014 May; 40(4):548-57. PubMed ID: 24360358
[TBL] [Abstract][Full Text] [Related]
35. [Retinal neovascularization and its therapeutic agents].
Nakamura S; Shimazawa M; Hara H
Nihon Yakurigaku Zasshi; 2010 Apr; 135(4):149-52. PubMed ID: 20410657
[No Abstract] [Full Text] [Related]
36. Advances in the synthesis of rearranged homoisoflavonoids.
Demidoff FC; Costa PRR; Caleffi GS
Org Biomol Chem; 2024 Jun; 22(24):4839-4863. PubMed ID: 38819298
[TBL] [Abstract][Full Text] [Related]
37. Homoisoflavonoids as potential antiangiogenic agents for retinal neovascularization.
Amin SA; Adhikari N; Gayen S; Jha T
Biomed Pharmacother; 2017 Nov; 95():818-827. PubMed ID: 28892793
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factors in retinal and choroidal neovascular diseases.
Kinnunen K; Ylä-Herttuala S
Ann Med; 2012 Feb; 44(1):1-17. PubMed ID: 21284527
[TBL] [Abstract][Full Text] [Related]
39. Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy.
Zhang SX; Ma JX
Prog Retin Eye Res; 2007 Jan; 26(1):1-37. PubMed ID: 17074526
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
